Table 1.
Clinical and sociodemographic characteristics of patients with major depression at inclusion.
| Sham tDCS | Active tDCS | p | |
|---|---|---|---|
| n | 18 | 21 | |
| Age (years) | 51.5 (9.7) | 48.1 (9.3) | 0.272 |
| Education | 15.0 (3.1) | 13.5 (2.8) | 0.129 |
| Sex (F/M) | 12/6 | 12/9 | 0.542 |
| Episode duration (months) | 15.86 (14.7) | 21.43 (14.8) | 0.138 |
| Illness duration (years) | 22.5 (13.7) | 21.8 (12.0) | 0.878 |
| MADRS10 | 26.8 (5.1) | 27.0 (4.9) | 0.918 |
| Maudsley | 6.5 (3.5) | 7.7 (2.5) | 0.243 |
| Antidepressant medication | |||
| SSRIs | 11 | 13 | 1.000 |
| SNRIs | 5 | 8 | 0.734 |
| TCAs | 6 | 5 | 0.723 |
| MAOIs | 1 | 1 | 1.000 |
| Other medication | |||
| BZD | 5 | 4 | 0.706 |
| Antipsychotics | 2 | 4 | 0.667 |
p: Student’s t-test, except for sex and medication (Fisher’s Exact test). Medication: Selective serotonin reuptake inhibitors (SSRIs); Serotonin-noradrenaline reuptake inhibitors (SNRIs); Tricyclic antidepressants (TCAs); Monoamine oxidase inhibitors (MAOIs), benzodiazepine (BZD).